YEP I love all the speculation for the past 25 years that .02 cents is coming and yet the company just filed a generic Percocet, a generic Narco and plans to file a generic Oxycontin this year.
Gee the company already earns 10 million a year on its generic pipeline so WHOOPSY on the company can't even capture $3 million.
No I'm not off on the share count doubling since the valuation - but feel free to offer actual facts to refute what I've said.
News 
Market Data 
Discover 
AI
